Navigation Links
Tennessee Oncology Chooses Navigating Cancer's Patient Engagement Portal

SEATTLE, May 7, 2013 /PRNewswire/ -- Navigating Cancer, the leading provider of oncology specific patient portals, announces that Tennessee Oncology has selected Navigating Cancer's Patient Engagement Portal for its practices and patients.  Navigating Cancer's portal will enable Tennessee Oncology to provide a more coordinated and patient-centered approach to the care it delivers to patients and help the practice meet all the new patient-centered care requirements.  With nearly 800 providers signed up for Navigating Cancer's Portal, Tennessee Oncology joins an established and expanding network of influential oncology practices that are working to improve healthcare by engaging patients in their care.  

Navigating Cancer's cloud-based Patient Engagement Portal integrates with any electronic medical record (EMR) system, enabling providers to easily and securely connect patients to their personal health information and educational resources.  More than 45,000 patients currently use Navigating Cancer to learn more about their condition, receive copies of their health information and stay connected with their healthcare team. Navigating Cancer helps practices meet many of the new patient-centered care requirements that are part of HITECH Meaningful Use, new medical home and accountable care organization models and updated care standards from professional organizations such as the American College of Surgeon's Commission on Cancer.

"Our focus is to provide innovative, exceptional cancer care that puts patients and their families first," said Jeff Patton , M.D., CEO of Tennessee Oncology. "This partnership gives our patients easy access to their personalized treatment information and resources to help them better understand their diagnosis, allowing them to be at the center of their care and well-equipped to make important healthcare decisions."

"Tennessee Oncology has a long-standing reputation for innovation and thought leadership in oncology, which translates to state-of-the-art cancer care for their patients," said Gena Cook , CEO of Navigating Cancer. "We're excited to work with Tennessee Oncology providers and patients and are looking forward to a strong partnership in the coming years as we work together to improve the quality and efficiency of care through the use of our service."

About Tennessee Oncology

Tennessee Oncology, PLLC is one of the nation's leading teams of cancer care specialists, nationally recognized for improving patient outcomes and innovative treatments. Its comprehensive range of cancer care services include specialized oncology nursing care, laboratory services, outpatient chemotherapy, PET/CT services and patient education and support services. Founded in 1976, Tennessee Oncology is one of the largest physician-owned practices in the country, employing more than 75 physicians in 30 locations throughout Middle Tennessee, Chattanooga, and Northwest Georgia. Visit for more information.

About Navigating Cancer

Navigating Cancer's mission is to transform healthcare through patient centered care by using technology to connect cancer patients to their healthcare team, their own health records, and the right information at the right time. Navigating Cancer's Patient Engagement Portal provides oncology clinics with a branded, online extension of their care model, empowering them to save time and money while providing better quality care. The company was founded in 2008 by technology and healthcare veterans and is based in Seattle, Washington.

SOURCE Navigating Cancer
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Tennessee Stop-Sale System Achieves Significant Results In Battle Against Meth
2. NEW POLL: Tennessee Voters Strongly Oppose Making Popular Cold and Allergy Meds Prescription Only
3. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
4. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
5. Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
6. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
7. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
8. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
9. Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
10. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
11. Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344
Post Your Comments:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):